BioSolar Inc. Rated 'Speculative Buy,' Target Price $.84 By Beacon Equity Research
Posted on: Wednesday, 19 September 2007, 09:02 CDT
BioSolar Inc. (OTCBB: BSRC) has been rated "Speculative Buy" with a target price of $.84 by Beacon Equity Research Analyst, Victor Sula, PhD.
The full report is available at http://www.BeaconEquityResearch.com
Anyone interested in receiving alerts regarding BioSolar Inc. research should email members@beaconequityresearch.com with "BSRC" in the subject line.
In the report, the analyst writes, "BioSolar, Inc. (BSRC) is developing innovative bioplastic solar cell components made from renewable plant sources. The Company's technology can help reduce the manufacturing cost per watt of solar cells; management anticipates substantial cost savings through the use of its bio-based plastics in solar cell production. The Company is targeting the market for solar cell back sheets, substrates and superstrates and intends to exploit the cost and application diversity advantages associated with its renewable bioplastic components."
Other companies in the solar development market include Suntech Power Holdings (NYSE: STP), First Solar Inc. (NASD: FSLR), Trina Solar (NYSE: TSL), and Evergreen Solar (NASD: ESLR).
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of BioSolar Inc. (BSRC). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Equity Research has been compensated a total of fifteen thousand dollars and one hundred thousand restricted rule 144 shares directly from the company for enrollment of BSRC in this research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
Source: Business Wire
Related Articles
- MarketsandMarkets Concentrated Solar Photovoltaic (PV) Market Analyst Briefing to be Held on 1st Dec 2009
- Research Provides Documentation That Tumor 'Stem-Like Cells' Exist In Benign Tumors
- Georgia Power Launches Solar Research Project
- Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
- Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
- Synova Teams With Fraunhofer ISE and Photovoltaic Manufacturing Leaders in European Solar Research Alliance
- Agere Systems Announces Low-Cost Cell Phone Platform for the Market's Largest Segment
- Research Seeks to Expand Use of Stem Cell Transplants
- 'Clean Coal' Cash Better Spent on Solar Research
- Researchers Work to Unlock Secrets of Body's Cell 'Janitors'
 |
 |
User Comments (0)
RSS Feeds